DCRM 3.0 update scheduled for September

An update to the previously published multispeciality guide for the management of diabetes, cardiorenal and metabolic diseases will be issued later this year with sweeping updates based on the latest data, a speaker reported.
Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, co-chair of Heart in Diabetes and medical director and principal investigator of the Metabolic Institute of America in Tarzana, California, provided an interim update on the DCRM 3.0 multidisciplinary recommendation document for management of diabetes, cardiorenal and metabolic diseases at the Heart in Diabetes CME

FDA approves Bayer’s Ambelvist for contrast-enhanced MRI

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest gadolinium-based contrast agent dose approved in the U.S, according to a press release from Bayer.
Ambelvist (gadoquatrane) allows for the detection and visualization of lesions with abnormal vascularity in adult and pediatric patients, including term neonates, according to the release.
The intravenous contrast agent can be used for lesions in the central nervous system — including the brain, spine and related tissues — as well as the head, neck, thorax, abdomen, pelvis and

Are ‘looksmaxxing’ men really hitting their jaws with hammers?

Every day, millions of people scroll through transformation videos on social media in pursuit of becoming the most attractive version of themselves. But for some young men, this goal has taken a dark turn.
Combining the terms “looks” and “maximizing,” a movement called “looksmaxxing” teaches young men that the key to success is to radically improve their physical appearance through any means necessary, according to an NPR article. While “looksmaxxing” strategies such as working out or optimizing skin care routines are usually harmless, a trend popularized on social media called “bonesmashing,”

Millions of people in US live in areas without grocery stores

Approximately 5 million people in the U.S. lived in communities with no access to grocery stores in 2023.
The number of food deserts in the country remained almost unchanged during the past 2 decades, whereas the number of areas with substantially more restaurants and fast-food locations than supermarkets increased more than 8 percentage points during the same time.
“Alarming,” Daniel Wiese, PhD, principal scientist in cancer disparity research at American Cancer Society, told Healio. “We might recommend people sustain a certain diet, but is it really possible?”
Prior research has shown poor

Is MAHA ready for the health challenges of rural America?

This month’s Healio Exclusive focuses on one of the most complex — and frankly saddest — realities in American health care: the profound unmet needs of rural populations, particularly with respect to access to care.
We also explore whether HHS Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” (MAHA) initiative is prepared to meaningfully address these challenges.
From the outset, I will attempt to approach this controversial topic by focusing on facts and avoiding, as best I can, the political maelstrom currently surrounding national health policy. That is easier said than done.

TRACK trial: Rivaroxaban fails to lower CV risks in advanced CKD

Treatment with low-dose rivaroxaban did not reduce risks for adverse CV events and increased risks for major bleeding among patients with advanced chronic kidney disease, according to data published in JAMA.
The results suggest that treatment decisions around anticoagulation may differ for patients with advanced CKD compared with other patient populations, according to Sunil V. Badve, PhD, professorial fellow at The George Institute for Global Health and the University of New South Wales in Sydney, and colleagues.
“Clinical decisions regarding anticoagulation in people with advanced kidney

Many men receive testosterone therapy without proper workup

CHICAGO — Most men who received testosterone therapy did not receive a workup in accordance with guidelines, and some received the treatment despite being contraindicated for it, researchers reported at ENDO 2026.
Sophia Sinha, MD, clinical assistant professor of internal medicine at the University of Michigan Medical School, and colleagues conducted a retrospective chart review of a random selection of 200 men (median age, 52.5 years; 76% with at least two comorbidities) who had at least one outpatient visit at Michigan Medicine, a diagnosis of hypogonadism and a prescription for testosterone

Nutrition gaps overlooked in adolescent depression

There are many risk factors for major depression among adolescents, but one of these risk factors, nutritional deficiencies, often gets overlooked.
“It is both common sense, and it’s scientifically valid,” said psychiatrist James Greenblatt, MD, author of Finally Hopeful: The Personalized, Whole-Body Plan to Find and Fix the Root Causes of Your Depression, with Bill Gottlieb, CPHC.
“In medical school, we learn that low thyroid and low iron and low B12 cause depression,” he told Healio. “But when you get out and practice, there are no child psychiatrists that are checking for iron, thyroid and

High vs. standard rocuronium dose shows benefit in intubation

ORLANDO — The probability for successful first-attempt intubation was greater among adults who received high- vs. standard-dose rocuronium, according to results presented at the American Thoracic Society International Conference.
This study was simultaneously published in American Journal of Respiratory and Critical Care Medicine.
“Among 1,822 adults receiving rocuronium as part of emergency airway intubation, recipients [of the high dose] had a higher probability of successful intubation on the first attempt,” Michael D. April, MD, DPhil, MSc, program director of SAUSHEC emergency medicine

Charity announces research prize to prevent food allergy

Natasha’s Foundation has opened applications for Natasha’s Prize, a £10 million research award aimed at finding out how to prevent food allergy by bringing different disciplines together, according to a press release from the charity.
Initial applications close on July 3, and the Foundation encourages allergists and scientists from other disciplines (AI data analysts, dieticians, engineers, social and environmental scientists, microbiologists and epidemiologists) to put their name forward.
If chosen, the process involves attending a 3-day Thinkery (Sandpit) in England in October and then